Polyubiquitination of p53 by a ubiquitin ligase activity of p300

被引:371
|
作者
Grossman, SR
Deato, ME
Brignone, C
Chan, HM
Kung, AL
Tagami, H
Nakatani, Y
Livingston, DM [1 ]
机构
[1] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[7] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA
关键词
D O I
10.1126/science.1080386
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Rapid turnover of the tumor suppressor protein p53 requires the MDM2 ubiquitin ligase, and both interact with p300-CREB-binding protein transcriptional coactivator proteins. p53 is stabilized by the binding of p300 to the oncoprotein E1A, suggesting that p300 regulates p53 degradation. Purified p300 exhibited intrinsic ubiquitin ligase activity that was inhibited by E1A. In vitro, p300 with MDM2 catalyzed p53 polyubiquitination, whereas MDM2 catalyzed p53 monoubiquitination. E1A expression caused a decrease in polyubiquitinated but not monoubiquitinated p53 in cells. Thus, generation of the polyubiquitinated forms of p53 that are targeted for proteasome degradation requires the intrinsic ubiquitin ligase activities of MDM2 and p300.
引用
收藏
页码:342 / 344
页数:3
相关论文
共 50 条
  • [1] Myocardial regulation of p300 and p53 by doxorubicin involves ubiquitin pathways
    Morimoto, Tatsuya
    Fujita, Masatoshi
    Kawamura, Teruhisa
    Sunagawa, Yoichi
    Takaya, Tomohide
    Wada, Hiromichi
    Shimatsu, Akira
    Kita, Toru
    Hasegawa, Koji
    [J]. CIRCULATION JOURNAL, 2008, 72 (09) : 1506 - 1511
  • [2] p300/CBP/p53 interaction and regulation of the p53 response
    Grossman, SR
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (10): : 2773 - 2778
  • [3] A TPR motif cofactor contributes to p300 activity in the p53 response
    Demonacos, C
    Krstic-Demonacos, M
    La Thangue, NB
    [J]. MOLECULAR CELL, 2001, 8 (01) : 71 - 84
  • [4] A novel cofactor for p300 that regulates the p53 response
    Shikama, N
    Lee, CW
    France, S
    Delavaine, L
    Lyon, J
    Krstic-Demonacos, M
    La Thangue, NB
    [J]. MOLECULAR CELL, 1999, 4 (03) : 365 - 376
  • [5] Binding and modulation of p53 by p300/CBP coactivators
    Lill, NL
    Grossman, SR
    Ginsberg, D
    DeCaprio, J
    Livingston, DM
    [J]. NATURE, 1997, 387 (6635) : 823 - 827
  • [6] Dual role of p300 in the regulation of p53 stability
    Kawai, H
    Nie, LH
    Wiederschain, D
    Yuan, ZM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (49) : 45928 - 45932
  • [7] Binding and modulation of p53 by p300/CBP coactivators
    Nancy L. Lill
    Steven R. Grossman
    Doron Ginsberg
    James DeCaprio
    David M. Livingston
    [J]. Nature, 1997, 387 : 823 - 827
  • [8] The ASPP proteins complex and cooperate with p300 to modulate the transcriptional activity of p53
    Gillotin, Sebastien
    Lu, Xin
    [J]. FEBS LETTERS, 2011, 585 (12) : 1778 - 1782
  • [9] p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity
    Shiseki, M
    Nagashima, M
    Pedeux, RM
    Kitahama-Shiseki, M
    Miura, K
    Okamura, S
    Onogi, H
    Higashimoto, Y
    Appella, E
    Yokota, J
    Harris, CC
    [J]. CANCER RESEARCH, 2003, 63 (10) : 2373 - 2378
  • [10] p19ARF inhibits ubiquitin ligase activity of Mdm2 for p53
    Honda, R
    Yasuda, H
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 489A - 489A